Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02279433
Title A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors AnHeart Therapeutics Inc.
Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST